Hypercalcemia is the most common life-threatening metabolic
disorder associated with cancer. The pathophysiological,
epidemiological and clinical aspects of hypercalcemia of malignancy
are presented in this issue, with a focus on the recently
discovered humoral factor responsible for the development of
hypercalcemia. With a better understanding of the pathophysiology
of this condition and the development of new potent drugs, capable
of inhibiting bone resorption, especially bisphosphonates, the
clinician will be more successful in correcting hypercalcemia in
the great majority of patients.
General
| Imprint: |
Springer-Verlag
|
| Country of origin: |
Germany |
| Series: |
Recent Results in Cancer Research, 137 |
| Release date: |
February 2012 |
| First published: |
1994 |
| Editors: |
Friedhelm Raue
|
| Dimensions: |
235 x 155 x 9mm (L x W x T) |
| Format: |
Paperback
|
| Pages: |
163 |
| Edition: |
Softcover reprint of the original 1st ed. 1994 |
| ISBN-13: |
978-3-642-85075-2 |
| Categories: |
Books >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology >
General
|
| LSN: |
3-642-85075-8 |
| Barcode: |
9783642850752 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
